Clinical Operations
Clinical Project ManagementStudy Monitoring and Site ManagementTrial Master File and Document ManagementQuality and Vendor Management SystemsStudy DocumentsRegulatory Affairs
Regulatory StrategyRegulatory WritingAgency Communications and SubmissionsDocument Editorial, QC and SubmissionQC, Review and RedactionLegal RepresentationPharmacovigilanceILAP SubmissionsMedical Communications
Publication PlanningStrategic CommunicationsScientific CommunicationsMedical EducationMedical IllustrationGrant Applications and Project PartnershipCase histories
Real programmes and real outcomes, from first-in-human studies to approval. See how biotech, pharma and academic partners have worked with Niche.
Respiratory
ReCode Therapeutics Inc.
“Niche have been involved in preparing many of our clinical and regulatory documents and they are also engaged in managing one of our Phase I/II studies.…”Dr John Matthews, CMO
Read the case history →
Oncology
Erytech Pharma SA
“In the highly pressurised situation of a start-up biotech with one final shot on goal, it needed the very best team to understand the challenges ahead…”Nigel Biswas-Baldwin, VP Med Affairs
Read the case history →
Neuroscience
DemeRx
“During my interactions with Niche I have always been impressed by the standard of the work delivered by the Niche teams. In addition, the contracting process…”Deborah C Mash, CEO & Founder
Read the case history →
Neuroscience
Cleothena Enterprises Pty Ltd
“Niche delivered high-quality work, including both a clinical protocol and an Investigator’s Brochure, allowing us to overcome our regulatory hurdle without losing pace on other projects.…”Basil Rigas, CEO
Read the case history →
Haematology
British Society for Haematology
“I am pleased by the standard of work delivered by Niche. The writers provide confidence in the written documents they produce and they excel at clear…”Rita Gupta, Guidelines Manager
Read the case history →
Trusted by biotech, pharma and research teams
All case histories
20 of 20 case histories
Respiratory
Clinical OperationsRegulatory Affairs
ReCode Therapeutics Inc.
Niche supported ReCode Therapeutics in launching their first UK patient study, delivering end-to-end clinical and regulatory operations for pioneering mRNA and gene correction therapies.
Read the case history →
Oncology
Regulatory Affairs
Erytech Pharma SA
Niche partnered with Erytech Pharma to rescue and rewrite substandard clinical study reports, delivering a high-quality regulatory package in support of their oncology BLA submission.
Read the case history →
Neuroscience
Clinical OperationsRegulatory Affairs
DemeRx
Niche provided DemeRx with end-to-end support to launch a pioneering ibogaine addiction trial, covering site identification, regulatory submissions, and interim medical leadership.
Read the case history →
Neuroscience
Regulatory Affairs
Cleothena Enterprises Pty Ltd
When stalled regulatory documentation threatened to derail their neurological programme, Cleothena turned to Niche — who delivered standout clinical protocols and an Investigator's Brochure with minimal client input.
Read the case history →
Haematology
Medical Communications
British Society for Haematology
Over a decade and 20+ guidelines later, Niche remains the BSH's trusted partner for raising haematology care standards through literature reviews, writing support and audit documentation.
Read the case history →
Cardiovascular
Medical CommunicationsRegulatory Affairs
Cardionetics
A partnership born in 2002, Niche has supported Cardionetics across medical writing, regulatory strategy and product value assessment for their pioneering ECG arrhythmia detection devices.
Read the case history →
Cardiovascular
Regulatory AffairsMedical Communications
Recardio Inc
From Phase 2 through to the global Phase 3 HEAL-MI trial, Niche has been Recardio's trusted writing and regulatory partner in advancing dutogliptin as a cardiac regeneration therapy.
Read the case history →
Multiple areas
Clinical OperationsRegulatory Affairs
Surface Logix Inc
Trusted as Legal Representative and on-the-ground CRO, Niche became integral to Surface Logix's EU clinical team, delivering four trials across three assets in just 24 months.
Read the case history →
Infectious disease
Medical Communications
ViiV Healthcare
Putting patients first, Niche supported ViiV Healthcare's global HIV outreach programmes with medical writing, communications planning and bespoke research into worldwide access to HIV medicines.
Read the case history →
Respiratory
Medical Communications
Synairgen plc
At the height of the pandemic, Niche's rapid manuscript writing helped Synairgen publish their landmark interferon beta COVID-19 trial results, unlocking the company's largest ever fundraising round.
Read the case history →
Rare disease and gene therapy
Regulatory Affairs
Orchard Therapeutics plc
Niche played a foundational role in securing EMA approval for Strimvelis, the world's first ex vivo autologous gene therapy, and continues supporting Orchard's pioneering rare disease pipeline.
Read the case history →
Infectious disease
Regulatory AffairsMedical Communications
Nabriva Therapeutics
Niche supported Nabriva's antibiotic lefamulin from early clinical protocols all the way to FDA, EMA and Health Canada approval — a decade-long writing partnership with a genuinely world-changing outcome.
Read the case history →
Neuroscience
Regulatory Affairs
EVERSANA
When an Alzheimer's programme hit a wall after two negative Phase III trials, EVERSANA called on Niche to make sense of the data and chart a credible path forward with regulators.
Read the case history →
Oncology
Regulatory Affairs
Adaptimmune
Niche delivered rigorous QC and medical writing support across Adaptimmune's full suite of regulatory documents, keeping pace with ambitious timelines on multiple TCR-based cancer therapy assets simultaneously.
Read the case history →
Ageing and frailty
Medical Communications
FRAILomic
Niche built and coordinated the full communications strategy for this 20-institution European initiative, turning complex frailty biomarker research into compelling content for academics, policymakers and the public alike.
Read the case history →
Respiratory
Clinical Operations
RASP-UK initiative
Since 2014, Niche has run the executive function of this £9.6 million MRC-funded consortium, overseeing seven clinical trials across 13 academic centres to personalise severe asthma treatment.
Read the case history →
Ageing and frailty
Clinical Operations
MID-Frail Study
When the original CRO walked out mid-trial, Niche stepped in to rescue and deliver this EU-funded, 74-site European study on frailty in older adults with type 2 diabetes.
Read the case history →
Oncology
Regulatory Affairs
Astex Pharmaceuticals
Niche provided Astex with expert regulatory writing across their oncology pipeline, delivering clinical protocols, study reports and safety narratives largely autonomously and to an exceptionally high standard.
Read the case history →
Medical devices
Medical Communications
ApaTech
Niche crafted a strategic communications plan for ApaTech's synthetic bone graft portfolio, translating preclinical science into compelling manuscripts, regulatory documents and conference publications ahead of its $330 million acquisition.
Read the case history →
Multiple areas
Regulatory Affairs
Assign DMB
For over a decade, Assign DMB relied on Niche as their embedded writing partner, seamlessly converting statistical outputs into polished clinical study reports across oncology, asthma and gastroenterology.
Read the case history →
No case history matches those filters yet.
Tell us where your programme is. We will tell you, honestly, how we can help.
Resources
Contact us
Address
Niche Science & Technology
Unit 26 Falstaff House
Bardolph Road
Richmond TW9 2LH
United Kingdom
Regular Updates